Clinical Trial Update: Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial of darbepoetin alfa in pediatric patients with anemia due to chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia, Chronic Kidney Disease | Phase 1 | Status: WITHDRAWN